Staphylococcus aureus and Antibiotics in Cutaneous T-Cell Lymphoma

Dermatology. 2022;238(3):551-553. doi: 10.1159/000517829. Epub 2021 Oct 7.

Authors

Lise M Lindahl¹, Lars Iversen², Niels Ødum³, Mogens Kilian⁴

Affiliations

¹ Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark, lise.lindahl@clin.au.dk.
² Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
³ LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
⁴ Department of Biomedicine, Aarhus University, Aarhus, Denmark.

PMID: 34619677
DOI: 10.1159/000517829

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Humans
Lymphoma, T-Cell, Cutaneous* / drug therapy
Microbial Sensitivity Tests
Skin Neoplasms* / drug therapy
Staphylococcal Infections* / drug therapy
Staphylococcus aureus

Substances

Anti-Bacterial Agents